Search - tctmd.com

Displaying 541 - 559 of 559

Sort: Relevancy | Date

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

Presentation TCT 2014

Hybrid Repair of Aortic Arch Aneurysm

Presenter: Sergey A. Abugov

September 13, 2014

Presentation TCT 2014

Update in Mitral Percutaneous Interventions: Who Should and Could Be Treated in 2014?

Presenter: Philippe Généreux, Nicolo Piazza

September 13, 2014

Presentation TCT 2014

TAVR Implantation in Degenerated Surgical Valves

Presenter: Alexey Protopopov

September 13, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Marco A. Alcocer-Gamba, Sunil V. Rao, Ramiro Trillo, Juan Alberto Quintanilla Gutierrez

September 13, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Marco A. Alcocer-Gamba, Sunil V. Rao, Ramiro Trillo, Javier Martin-Moreiras

September 13, 2014

Presentation TCT 2014

Patient #2: How Can I Treat This 52 Year Old Patient with LF, LG, and Critical AS with Severely Depressed LVEF?

Presenter: Marco A. Alcocer-Gamba, Sunil V. Rao, Ramiro Trillo, Juan Alberto Quintanilla Gutierrez

September 13, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Marco A. Alcocer-Gamba, Sunil V. Rao, Ramiro Trillo, Rodrigo Estevez

September 13, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Marco A. Alcocer-Gamba, Sunil V. Rao, Ramiro Trillo, José Alfredo Merino Rajme

September 13, 2014

Presentation TCT 2014

Patient #1: How Can I Leave This TAVI in Place?

Presenter: Marco A. Alcocer-Gamba, Sunil V. Rao, Ramiro Trillo, Rodrigo Estevez

September 13, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 29, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

Presentation TCT 2013

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger, Bryce Einhorn, Vladimir Jelnin, Leandro Maranan, Gila Perk, itzhak kronzon, Howard Cohen, Carlos Ruiz

January 31, 2013

News Conference News TCT 2012

Type of Vascular Access Not Linked to Silent Cerebral Infarcts

October 25, 2012

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

News Conference News

Caution Urged in Widespread Adoption of TAVR

November 08, 2011

Video

» Live Case

Live Case - TTVR and Tricuspid Valve Interventions- From Clinical Trials to Clinical Practice Sinai Medical Center, Los Angeles, CA

November 12, 2024

Video

» Interview

Beyond the Data: Tricuspid Valve Interventions

October 26, 2023

Advertisement

Lively Debate on Use of TAVR for Lower-Risk Patients

Hybrid Repair of Aortic Arch Aneurysm

Update in Mitral Percutaneous Interventions: Who Should and Could Be Treated in 2014?

TAVR Implantation in Degenerated Surgical Valves

How Did I Treat This Patient?

How Would I Treat This Patient?

Patient #2: How Can I Treat This 52 Year Old Patient with LF, LG, and Critical AS with Severely Depressed LVEF?

How Did I Treat This Patient?

How Would I Treat This Patient?

Patient #1: How Can I Leave This TAVI in Place?

Innovation in Intervention: Perspectives from Industry

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Type of Vascular Access Not Linked to Silent Cerebral Infarcts

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Caution Urged in Widespread Adoption of TAVR

Live Case - TTVR and Tricuspid Valve Interventions- From Clinical Trials to Clinical Practice Sinai Medical Center, Los Angeles, CA

Beyond the Data: Tricuspid Valve Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content